N-(aroyl) glycine hydroxamic acid derivatives and related compounds
US6225351A · kind A · utility
0Cited by
11References
13Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 6, 1998 |
| Grant date | May 1, 2001 |
| Priority date | — |
| Expiry date | Jul 6, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C2601/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein R.sup.1, R.sup.2, AA and Y are as defined herein, inhibit phosphodiesterase type IV or inhibit the production of tumor necrosis factor, and therefore are useful in the treatment of certain conditions and diseases including asthma, arthritis, and sepsis. ##STR1##
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.